Maurice Blackburn has dropped its investigation of a possible class action on behalf of owners of units in Sydney’s faulty Opal Tower, but Corrs Chambers Westgarth is still pursuing a potential case.
Rival law firms backpedal in deal over competing Commonwealth Bank class actions
Class action threat hurt Boart Longyear scheme vote, judge says
Merck Sharp & Dohme slams Wyeth vaccine patent claims as ‘hearsay and speculation’
Claims by Wyeth that its patented Prevnar 13 pneumococcal vaccine was inventive because other pharmaceutical giants had failed in developing similar vaccines are based on “hearsay and speculation,” Merck Sharp & Dohme told the court during closing submissions in the high-stakes trial over the world’s best-selling vaccine.